Strong Valeant Earnings Buoy Talk Of Heftier Allergan Bid
Rounding the six-month mark in its $53 billion hostile pursuit of Allergan Inc., Valeant Pharmaceuticals International Inc. hinted it could raise its bid for the Botox maker after it said strong...To view the full article, register now.
Already a subscriber? Click here to view full article